论文题目: | Phosphatase Wip1 Controls the Development of Th9 Cells and Allergic Airway Inflammation |
论文题目英文: | |
作者: | 王鹏①,苏会婷①,张连军①,陈辉①,胡雪莲,杨帆,#闾军*,#张连峰*,赵勇* |
论文出处: | |
年: | 2017 |
卷: | |
期: | DOI: 10.1016/j.jaci.2017.06.026 |
页: | |
联系作者: | #闾军,#张连峰,赵勇 |
发表期刊: | Journal of Allergy and Clinical Immunology |
ISSN: | |
第一作者所在部门: | |
收录类别: | |
论文连接 | http://www.sciencedirect.com/science/article/pii/S0091674917311065 |
影响因子: | |
摘要: | BackgroundAllergic asthma is one of the most common diseases worldwide, resulting in a burden of diseases. No available therapeutic regimens can cure asthma so far. ObjectiveTo identify new molecular targets for Th9 cells-mediated allergic airway inflammation. MethodsWild-type p53-induced phosphatase 1 (Wip1) gene knockout mice, Wip1 inhibitor-treated mice and ovalbumin (OVA)-induced allergic airway inflammation mouse models were employed to characterize the roles of Wip1 in allergic airway inflammation. The induction of Th cell subsets in vitro, real-time PCR, immunoblots, luciferase assay and ChIP assays were employed to determine the regulatory pathways of Wip1 in Th9 differentiation. ResultsWe herein demonstrate that Wip1-deficient mice are less prone to allergic airway inflammation as indicated by the decreased pathological alterations in lungs. Short-term treatment of Wip1-specific inhibitor significantly ameliorates allergic inflammation progression. Intriguingly, Wip1 selectively impaired Th9 cell but not Th1, Th2 and Th17 cell differentiation. Biochemical assays show that Wip1 deficiency increases c-Jun/c-Fos activity in a JNK-dependent manner and that c-Jun/c-Fos directly binds to Il-9 promoter and inhibits Il-9 transcription. ConclusionPhosphatase Wip1 controls Th9 cell development through regulating c-Jun/c-Fos activity on Il-9 promoter and is important for the pathogenesis of allergic airway inflammation. These findings shed lights on the previously unrecognized roles of Wip1 in Th9 cell differentiation. The inhibitory effects of a Wip1 inhibitor on the pathogenesis of allergic airway inflammation may have important implications for clinical application of Wip1 inhibitors in allergy therapies. |
英文摘要: | |
外单位作者单位: |